| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | BullFrog AI Unveils Decision Engine To Tackle Drug Development Uncertainty | 2 | Benzinga.com | ||
| Mi | BullFrog AI Holdings, Inc.: BullFrog AI Unveils bfARENAS Scenario-based Decision Engine | 1 | GlobeNewswire (USA) | ||
| 19.03. | BullFrog AI Holdings, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| BULLFROG AI Aktie jetzt für 0€ handeln | |||||
| 17.02. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 04.02. | BullFrog AI Holdings, Inc.: BullFrog AI to Unveil New Precision AI Capability | 521 | GlobeNewswire (Europe) | New capabilities to be launched on March 25Unique technology bolsters BullFrog AI's end-to-end AI intelligence workflow with a scenario-based decision engineAdvances current AI decision tools by clearly... ► Artikel lesen | |
| 27.01. | BullFrog AI Holdings, Inc.: BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences | 2 | GlobeNewswire (USA) | ||
| 06.01. | BullFrog AI Holdings, Inc.: BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer | 2 | GlobeNewswire (USA) | ||
| 30.12.25 | BullFrog AI: Aktionärsbrief veröffentlicht und Kapitalmaßnahme genehmigt | 3 | Investing.com Deutsch | ||
| 30.12.25 | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.12.25 | BullFrog AI Holdings, Inc.: BullFrog AI Publishes Annual Letter to Shareholders | 178 | GlobeNewswire (Europe) | GAITHERSBURG, Md., Dec. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial... ► Artikel lesen | |
| 28.11.25 | RedChip Companies, Inc.: BullFrog AI and Myriad Uranium Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 1.929 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / November 28, 2025 / RedChip Companies will air interviews with BullFrog AI, Inc. (Nasdaq:BFRG) and Myriad Uranium Corp. (OCTQB:MYRUF) on the RedChip Small Stocks, Big... ► Artikel lesen | |
| 18.11.25 | BullFrog AI Holdings, Inc.: BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights | 4 | GlobeNewswire (USA) | ||
| 24.10.25 | BullFrog AI: Aktionäre stimmen für Kapitalerhöhung und Aktienzusammenlegung | 4 | Investing.com Deutsch | ||
| 24.10.25 | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.10.25 | RedChip Companies, Inc.: BullFrog AI and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 459 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / October 24, 2025 / RedChip Companies will air interviews with BullFrog AI, Inc. (Nasdaq:BFRG) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Small Stocks... ► Artikel lesen | |
| 10.10.25 | Bullfrog AI files to sell 5M shares of common stock for holders | 4 | Seeking Alpha | ||
| 10.10.25 | BullFrog AI Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 09.10.25 | BullFrog AI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.07.25 | RedChip Companies, Inc.: Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 507 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / July 18, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and BullFrog AI, Inc. (Nasdaq:BFRG) on the RedChip Small... ► Artikel lesen | |
| 11.04.25 | RedChip Companies, Inc.: Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 540 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / April 11, 2025 / RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BB BIOTECH | 46,050 | -2,54 % | Dividendenbekanntmachungen (23.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABB LTD CH0012221716 0,94 CHF 1,0309 EUR AECON GROUP INC CA00762V1094 0,1925 CAD 0,1212 EUR AMPHENOL CORPORATION US0320951017 0... ► Artikel lesen | |
| QIAGEN | 33,900 | -3,32 % | QIAGEN N.V.: Qiagen Announces Form 20-F Annual Report Filing for 2025 Results | QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended... ► Artikel lesen | |
| AMGEN | 306,75 | -0,11 % | Wells Fargo Raises its Price Target on Amgen (AMGN) to $390 from $375 | ||
| NOVAVAX | 7,791 | -0,93 % | FOMO an der Wall Street: Novavax meldet überraschenden Gewinn - Aktie schießt zweistellig hoch | © Foto: picture alliance / Ulrich Baumgarten | Ulrich BaumgartenEin Ergebnis, das niemand erwartet hatte, gepaart mit neuen Big-Pharma-Deals: Novavax sorgt für FOMO an der Wall Street. Wie lange hält... ► Artikel lesen | |
| STRYKER | 290,00 | +0,10 % | Stryker: IT läuft nach Cyberangriff wieder | ||
| ILLUMINA | 102,14 | -5,44 % | Argus hebt Illumina-Kursziel wegen neuer Produkte auf 145 US-Dollar an | ||
| CRISPR THERAPEUTICS | 39,600 | -3,88 % | AtaiBeckley added to S&P Total Market, CRSP benchmark indices | ||
| AAP IMPLANTATE | 1,320 | -4,35 % | AAP Implantate AG - Schwächer, aber nicht richtungslos | ||
| OCUGEN | 1,615 | -4,95 % | Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration | Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (pPotential 2X treatment benefit compared to 15% and 22% reductions... ► Artikel lesen | |
| SANGAMO THERAPEUTICS | 0,290 | -3,14 % | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease | Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally... ► Artikel lesen | |
| INTELLIA THERAPEUTICS | 10,710 | -7,19 % | Intellia Therapeutics, Inc.: Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM | CAMBRIDGE, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing... ► Artikel lesen | |
| TEMPUS AI | 36,800 | -7,54 % | Tempus AI Enters Collaboration With Daiichi Sankyo | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Tempus AI announced a strategic collaboration with Daiichi Sankyo (4568.T) for accelerating the clinical development and differentiation of an antibody drug... ► Artikel lesen | |
| SCORPIUS | 0,070 | 0,00 % | Scorpius Holdings, Inc. - 8-K, Current Report | ||
| DEFENCE THERAPEUTICS | 0,345 | -4,96 % | Defence Therapeutics Inc: Defence extends warrant expiry, lowers exercise price | ||
| EDITAS MEDICINE | 2,041 | +0,79 % | Editas Medicine, Inc.: Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference | CAMBRIDGE, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today... ► Artikel lesen |